Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Pharmaceutical Preparations

https://www.cadrenal.com

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

822 A1A NORTH, SUITE 300
PONTE VEDRA, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/20/2023

Market Cap

7,259,841

Shares Outstanding

13,020,000

Weighted SO

13,022,754

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

MLYS --.--%

MLYS --.--%

GPCR --.--%

CNTA --.--%

CNTA --.--%

NVCT --.--%

NVCT --.--%

SNTI --.--%

SNTI --.--%

Beta

0.0000

Last Div

0.0000

Range

0.36-2.17

Chg

-0.0505

Avg Vol

136595

Mkt Cap

7259841

Exch

NASDAQ

Country

US

Phone

904 300 0701

DCF Diff

-0.1739

DCF

0.6436

Div Yield

0.0000

P/S

2622.7749

EV Multiple

-0.3422

P/FV

1.8185

Div Yield %

0.0000

P/E

-1.1640

PEG

0.1125

Payout

0.0000

Current Ratio

3.5989

Quick Ratio

3.5989

Cash Ratio

3.4385

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

122611.2649

CCC

-122611.2649

Gross Margin

0.1832

Op Margin

-2394.7493

Pretax Margin

-2253.1723

Net Margin

-2253.1723

Eff Tax Rate

-0.0170

ROA

-1.1429

ROE

-0.9371

ROCE

-1.6604

NI/EBT

1.0000

EBT/EBIT

0.9409

EBIT/Rev

-2394.7493

Debt Ratio

0.0016

D/E

0.0022

LT Debt/Cap

0.0000

Total Debt/Cap

0.0022

Int Coverage

488.5875

CF/Debt

-532.9519

Equity Multi

1.3669

Rec Turnover

0.0000

Pay Turnover

0.0030

Inv Turnover

0.0000

FA Turnover

0.2803

Asset Turnover

0.0005

OCF/Share

-0.2928

FCF/Share

-0.2930

Cash/Share

0.3147

OCF/Sales

-1693.5856

FCF/OCF

1.0007

CF Coverage

-532.9519

ST Coverage

-532.9519

CapEx Coverage

-1440.1982

Div&CapEx Cov

-1440.1982

P/BV

1.8185

P/B

1.8185

P/S

2622.7749

P/E

-1.1640

P/FCF

-1.5476

P/OCF

-1.5487

P/CF

-1.5487

PEG

0.1125

P/S

2622.7749

EV Multiple

-0.3422

P/FV

1.8185

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation